Healthcare Investing in 2026: iShares Global Healthcare ETF Outperforms Invesco Health Care ETF

IXJ (iShares Global Healthcare ETF) has demonstrated relative outperformance versus RYH (Invesco Health Care ETF) over a five-year horizon, driven by its market-cap weighting methodology and diversified international exposure. This structural advantage has translated into both superior returns and materially lower volatility, suggesting the global approach better captures healthcare sector dynamics across developed and emerging markets.

The dividend yield differential—with IXJ offering approximately double that of RYH—reflects both the composition of underlying holdings and the broader valuation environment within global health care equities. This income component becomes increasingly relevant in higher-rate environments and appeals to yield-focused institutional allocators. The performance gap suggests market-cap weighting has outpaced sector-specific or thematic selection approaches in recent years.

The comparison highlights a critical investor consideration: passive global diversification versus concentrated domestic health care exposure. IXJ's international tilt provides exposure to non-U.S. pharmaceutical, medical device, and biotech firms, reducing single-market regulatory and currency concentration. This structural diversification likely explains both the volatility reduction and return persistence observed in the five-year period analyzed.

Sector implication: Health Care remains a defensive, growth-resistant sector attracting both income and stability-focused capital. The relative strength of globally-diversified vehicles over domestically-concentrated ETFs signals investor preference for geographic hedging within defensive allocations, particularly as healthcare valuations remain elevated relative to historical averages.